New England Peptide designs and manufactures custom peptides and polyclonal antibodies primarily for the therapeutic, vaccine, diagnostic and cosmetics markets. NEP markets to research scientists at pharmaceutical companies, biotech companies, academic institutions, and government agencies throughout the nation and world.

Applications

NEP’s clients use its peptides and antibodies for drug discovery purposes in therapeutic and diagnostic areas, including:

Oncology/Cancer

HIV/AIDS

Cardiovascular

Diabetes

Metabolic disease (e.g., diabetes)

Infection

Central nervous system

Dermatology

Key Facts

NEP, founded in 1998, employs a scientific team with more than a collective century of peptide production experience.

NEP has long-standing partnerships with the most recognizable and promising drug discovery companies in the major research hubs across the United States and in more than 30 countries.

NEP is one of the few independently owned and operated peptide/antibody producers in the world.

NEP has developed a highly automated, proprietary production process.

NEP has a dedicated production R&D group to continually create innovative production methodologies.

NEP leverages its formal collaborations with leading peptide equipment manufacturers, ensuring that it remains at forefront of production technologies.

NEP’s proprietary software program (PepTrend™) facilitates the design and production of custom peptides.

NEP offers a 100 percent satisfaction guarantee on its products.

NEP provides on-demand, direct access to peptide chemists as questions arise.

Web site: www.newenglandpeptide.com

Founded: 1998

Headquarters:

65 Zub Lane
Gardner, MA 01440
(978) 630-0020

Contacts:

Sam Massoni, CEO
New England Peptide
(978) 630-0020
sam.massoni@newenglandpeptide.com